Evidence map›Paper›PMID 36633616›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2023

TCR repertoire landscape reveals macrophage-mediated clone deletion in endotoxin tolerance.

Juanjuan Zhao, Li Jia, YiJing Tao, Xu Zhao, Jing Yang, Yanxin Lu, Yaping Yan, Ling Mao, Lin Hu, Jia Lu and 6 more

Open access · hybridFull text read
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Juanjuan Zhao *Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Li Jia *Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
YiJing Tao *Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Xu ZhaoSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Jing YangSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Yanxin LuSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Yaping YanSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Ling MaoSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Lin HuSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Jia LuSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
MengMeng GuoSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Chao ChenSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China.
Ya ZhouDepartment of Medical Physics, Zunyi Medical University, Zunyi, China.
Zhenke WenJiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, 215123, Jiangsu, China. zkwen@suda.edu.cn.
Zhixu HeCollaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine, Zunyi Medical University, Zunyi, 563000, Guizhou, China. hzx@gmc.edu.cn.
Lin XuSpecial Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi, China. xulinzhouya@163.com.
Zunyi Medical University · CNGuizhou Provincial Education Department · CNSoochow University · CN

Funding

Collaborative Innovation Center of Chinese Ministry of Education 2020-39National Natural Science foundation of China 32160178, 32270848Project of the Guizhou Provincial Department of Science and Technology QKH-2019-5406, QKHRC-2019-5612, QKHZC-2020-4Y156, QKH-JC-ZK2022-623
6 · The paper itself

Abstract

backgroundEndotoxin tolerance (ET) is a protective mechanism in the process of sepsis, septic shock, and their sequelae including uncontrolled inflammation. Accumulating evidence has shown that peripheral T cells contribute to the induction of ET. However, what and how T-cell development contributes to ET inductions remain unclear.

methodsMice were intraperitoneally injected with LPS at a concentration of 5 mg/kg to establish an LPS tolerance model and were divided into two groups: a group examined 72 h after LPS injection (72-h group) and a group examined 8 days after LPS injection (8-day group). Injection of PBS was used as a control. We performed high-throughput sequencing to analyze the characteristics and changes of CD4

resultsWe found that the frequency and characteristics of the TCRβ chain CDR3 changed obviously under condition of ET, indicating the occurrence of TCR rearrangement and thymocyte diversification. Moreover, the absolute numbers of F4/80

conclusionsThese data reveal that the frequency and characteristics of the TCRβ chain CDR3 undergo dynamic programming under conditions of LPS tolerance. Furthermore, the peripheral macrophages may be a key factor which carry peripheral antigen to thymic medulla and affect the negative selection of T-cell population, thereby contributing to the formation of ET. These results suggest that the clone selection in thymus in ET may confer protection against microbial sepsis.

Indexed as

Endotoxin ToleranceLipopolysaccharidesAnimalsClone CellsMiceReceptors, Antigen, T-CellThymus GlandT-LymphocytesLipopolysaccharidesReceptors, Antigen, T-CellClone deletionEndotoxin toleranceMacrophageTCR repertoire

Identifiers

PMID36633616
PMCPMC10023648
OpenAlexW4315754646

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read24
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.